Committee
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 60 of 2876
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 11:04
I call this meeting to order.
Welcome to meeting number 30 of the House of Commons Standing Committee on Health. Today we're going to meet for two hours with witnesses on our study of children's health.
Today's meeting is taking place in a hybrid format, pursuant to the House order of June 23, 2022.
I'd like to make a few comments for the benefit of witnesses and members.
Please wait until I recognize you before speaking. For those participating by video conference, click on the microphone icon to activate your mike, and please mute yourself when you're not speaking. For interpretation for those on Zoom, you have the choice, at the bottom of your screen, of floor, English or French. For those of you in the room, you can use the earpiece and select the desired channel.
Screenshots or taking photos of your screen is not permitted. The proceedings will be made available via the House of Commons website.
In accordance with our routine motion, I am informing the committee that all witnesses have completed their required connection tests in advance of the meeting.
We are welcoming a new committee member, Mr. Perron, whom I welcome.
I see Ms. Vien is filling in. Welcome. It's nice to have you here.
I would like to welcome the witnesses who are with us this afternoon. It's an absolute pleasure, after so long, to see witnesses physically present, so a warm welcome to you.
Appearing as an individual is Dr. Michael Ungar, Canada research chair in child, family and community resilience, resilience research centre, Dalhousie University—my alma mater. We have the Canadian Cancer Society, represented by Kelly Masotti, vice-president of advocacy, and Helena Sonea, director of advocacy. From the Canadian Dental Association, we have Dr. Lynn Tomkins, president, and Dr. Aaron Burry, chief executive officer. From Pharmascience, we have Sarah Douglas, senior manager of government affairs. From Speech-Language & Audiology Canada, we have Dawn Wilson, chief executive officer, and Anne Carey, director of speech-language pathology and communication health assistants.
Thank you all for taking the time to appear today. As I believe you were informed, each organization has up to five minutes for an opening statement. I'm going to invite Dr. Ungar to begin.
Dr. Ungar, welcome to the committee. You now have the floor.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 11:12
Thank you very much, Dr. Ungar.
Next we're going to hear from Dr. Tomkins of the Canadian Dental Association.
You have the floor for the next five minutes. Welcome.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 11:17
Thank you very much, Dr. Tomkins.
Next, from Pharmascience, we have Sarah Douglas.
Ms. Douglas, you have the floor.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 11:22
Thank you very much, Ms. Douglas.
Next, from Speech-Language and Audiology Canada, I believe Dawn Wilson will be speaking for the group.
You have the floor for the next five minutes. Welcome to the committee.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 11:28
Thank you very much, Ms. Wilson.
Next, we're going to hear from the Canadian Cancer Society.
Ms. Masotti, I know you had some trouble getting online, but I see you there now. I know you're no stranger to parliamentary committees. You know the drill. You have the floor for the next five minutes. Thanks for your patience, and welcome.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 11:36
Thanks to you both.
We're now going to proceed directly to questions, beginning with Mr. Barrett for six minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 11:43
Thank you, Ms. Sonea.
Thank you, Mr. Barrett.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 11:43
Thank you, Mr. Barrett.
Next we have Ms. Sidhu, please, for six minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 11:50
Thank you, Ms. Sidhu and Ms. Masotti.
Mr. Perron, go ahead for six minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 11:56
Thank you, Mr. Perron. Your time is up.
Next is Mr. Davies, please, for six minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 11:56
Thank you.
Mr. Davies, go ahead, please.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:03
Thank you, Ms. Wilson.
Thank you, Mr. Davies.
Next, we'll have Dr. Ellis, please, for five minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:08
Thank you, Dr. Ellis.
Next, we have Mr. van Koeverden, please, for five minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:14
Thank you, Dr. Ungar and Mr. van Koeverden.
Mr. Perron, you have two and a half minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:18
Thank you, Dr. Ungar.
Thank you, Mr. Perron.
Next we have Mr. Davies, please, for two and a half minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:20
Thank you, Mr. Davies.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:21
Mr. Davies, that's your time.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:21
Thank you.
You're more than welcome to follow up with a written brief. We're going to move on.
Mrs. Goodridge, please go ahead for five minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:22
The question was posed after your time was up. You will get another turn, Mr. Davies.
Mrs. Goodridge, go ahead for five minutes, please.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:27
Thank you, Mrs. Goodridge.
Next is Dr. Hanley, please, for five minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:33
Thank you, Ms. Masotti and Dr. Hanley.
Next, we have Dr. Ellis, please, for five minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:39
Thank you, Dr. Ungar and Dr. Ellis.
Next is Mr. Jowhari.
Go ahead, please, for five minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:45
Thank you, Dr. Tomkins.
Thank you, Mr. Jowhari.
Mr. Perron, you have two and a half minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:48
Give a brief response if you can, please, Doctor.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:49
Thank you, Mr. Perron.
Mr. Davies, go ahead for two and a half minutes, please.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:52
Thank you, Ms. Douglas and Mr. Davies.
Next is Dr. Ellis, please, for five minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 12:57
Thank you, Dr. Ellis.
The last round of questions will be posed by Dr. Powlowski.
You have the floor for five minutes, sir.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-09-22 13:03
Thank you, Dr. Ungar.
Thank you, Dr. Powlowski.
That concludes our rounds of questions.
To all of the panellists, thank you so much for being here with us today. This is our first witness panel on this study, the first of six we have planned. It's a very broad topic, and I think the diversity of expertise that we had in the room today reflects how broad the topic is.
Thank you very much for sharing your expertise and experience with us. I have no doubt that it will be of great value in framing our thinking as we move through this work. We are, indeed, grateful to you for the time that you've given us and the thoughtful and comprehensive way in which you've addressed all of the questions.
Is it the will of the committee to adjourn the meeting?
Some hon. members: Agreed.
The Chair: We're adjourned.
View Heath MacDonald Profile
Lib. (PE)
View Heath MacDonald Profile
2022-09-21 17:55
Thank you, Mr. Chair.
I want to continue this conversation just a little bit with the Canadian Taxpayers Association. In one phrase, you talked about accountability and then you related it to health care. We're actually dealing with accountability issues in health care on transfer payments to the provinces.
I'm a little confused by your comments. You're talking about accountability in one sense, but in the other sense, it's a confusing message. I just want you to clarify the accountability measures in health care and the transfer payments to the provinces.
View Heath MacDonald Profile
Lib. (PE)
View Heath MacDonald Profile
2022-09-21 17:57
Thank you.
I'm going to flip right to the Canadian Health Coalition.
Look, this is all kind of entangled, to use that term loosely. We've seen that some provinces, such as Quebec and British Columbia, are calling for large Canada health transfers and for increases while cutting taxes and running large surpluses. The Canadian Centre for Policy Alternatives has published a report noting that the Province of Ontario, for example, has reduced its own revenues by $7.5 billion.
What role do provinces play in our health care systems? Could the Canadian Health Coalition respond to that, please?
View Robert Morrissey Profile
Lib. (PE)
View Robert Morrissey Profile
2022-06-21 12:23
Thank you, Chair.
My question is for Dr. Vascotto.
Numerous witnesses appearing before the committee have referenced the DFO modelling. It's something that I am not familiar with at all. A retired senior DFO manager referenced the Scandinavian stock model.
Dr. Vascotto, are you familiar with DFO modelling? Is it accurately capturing the data that's going in, in an effective manner, so as to get the right decision coming out?
View Robert Morrissey Profile
Lib. (PE)
View Robert Morrissey Profile
2022-06-21 12:25
Okay. Thank you.
My next question is for Mr. LeBlanc.
Leonard, you referenced, in your written brief to the committee, the need for better collaboration between the fisher experience and DFO. We've heard this extensively in this report about the sometimes inability of fisher knowledge to find its way into the science-based decision-making process at DFO.
My question for you is a candid one. When the minister announces an increase in stocks, nobody questions the science, including fishers. The minute you start cutting the quota, then everybody starts to question the science. What would you recommend to this committee for its recommendations to the minister that the information provided by fishers is valid and can be taken into the consideration process? Could you give us your opinion on that?
View Robert Morrissey Profile
Lib. (PE)
View Robert Morrissey Profile
2022-06-21 12:28
Thank you, Leonard. That's a valid point, and actually, that's the first time we've heard that. If you could provide anything in a written form to us on how you would like to see fisher knowledge incorporated into the department's scientific decisions, it would be appreciated.
Thank you.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 16:06
I call this meeting to order.
Welcome to meeting number 28 of the House of Commons Standing Committee on Health. Today, we're meeting for a one-hour briefing on labour shortages in the health care sector and the foreign credential recognition program. In the second hour, we'll have a briefing from the Public Health Agency of Canada in relation to the study of the emergency situation facing Canadians in light of the COVID-19 pandemic.
I'll forgo the usual announcement on hybrid proceedings. We're all quite familiar with them at this point, as are the officials who are appearing before us.
I would like it if we could do this right off the top, folks, because I always tend to forget this at the end. I'd like to set a deadline for the submission of witness lists for the children's health study that we will be resuming in September. After discussions with the clerk, I'm going to make a suggestion of July 18. The clerk will send out a reminder a couple of weeks before the deadline.
Is July 18 for witness lists on the children's health study okay?
Some hon. members: Agreed.
The Chair: It's adopted by consensus. Thank you.
In accordance with our routine motion, I'm informing the committee that all witnesses have completed the required connection tests in advance of the meeting.
I will now welcome our witnesses who are with us for the first hour this afternoon. From the Department of Employment and Social Development, we have Andrew Brown, senior assistant deputy minister of the skills and employment branch, and Erin Connell, director, skilled newcomers, employment integration and partnership, of the skills and employment branch.
We're going to begin with the five-minute opening statement, if one of you has an opening statement to present.
Welcome to the committee. You now have the floor.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 16:17
Thank you very much, Mr. Brown.
We're now going to rounds of questions beginning with the Conservatives.
Dr. Ellis, please, you have six minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 16:24
Thank you, Mr. Brown and Dr. Ellis.
Next we're going to go to Dr. Powlowski, please.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 16:32
Go ahead. Finish your thought, Mr. Brown, and then we'll move to Mr. Garon.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 16:32
Thank you, Mr. Brown and Dr. Powlowski.
Mr. Garon, you may go ahead. You have six minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 16:39
Thank you, Mr. Brown.
Next, we have Mr. Bachrach, please, for six minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 16:45
Thank you, Ms. Connell and Mr. Bachrach.
We'll now go back to Dr. Ellis, please, for five minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 16:51
Ms. Connell, we're past time. You can provide a response, without interruption, if you like.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 16:51
Next we have Mr. Jowhari, please, for five minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 16:56
Give a brief response, please.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 16:56
Thank you, Ms. Connell.
We now go to Mr. Garon for two and a half minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 16:59
Please keep your answer brief.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:00
Thank you, Mr. Garon.
Next we have Mr. Bachrach for two and a half minutes. We'll then go to the next panel.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:03
Thank you, Mr. Brown and Mr. Bachrach.
Mr. Brown and Ms. Connell, I want to thank you very much for being with us here today. We've spent a significant amount of time in recent months studying the challenges around the workforce in health care. If there is one thing that we've learned, it's that foreign credentialing is absolutely part of the solution.
Thanks for the work you have been doing in this area. Thanks for the information that you provided to us today, and for your patience with the late start. It's become more of the norm in recent weeks.
With that, colleagues, we will suspend while we have the next panel geared up.
The meeting is suspended.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:06
I call the meeting back to order.
We will now proceed to our briefing from Public Health Agency of Canada officials under our study of the emergency situation facing Canadians in light of the COVID-19 pandemic.
We're pleased to welcome, from the Public Health Agency of Canada, Kathy Thompson, executive vice-president; Cindy Evans, vice-president, emergency management branch; Stephen Bent, vice-president, vaccine rollout task force; Kimby Barton, acting vice-president, health security and regional operations branch; and Dr. Guillaume Poliquin, vice-president, national microbiology laboratory.
Thank you all for taking the time to appear today.
I understand, Ms. Thompson, that you're going to be delivering opening remarks on behalf of the agency, so you have the floor for the next five minutes. Welcome to the committee.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:12
Thank you very much, Ms. Thompson.
We will now begin with rounds of questioning, starting with Mr. Ellis, for six minutes, please.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:16
To Ms. Goodridge or to the next person on the list...?
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:16
Thank you, Mr. Ellis.
Next, we have Mr. Hanley for six minutes, please.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:22
Yes, indeed. You have one full minute.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:23
Thank you, Mr. Bent.
Mr. Garon, go ahead. You have six minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:30
Thank you, Dr. Poliquin and Mr. Garon.
We'll have Mr. Bachrach, please, for six minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:37
Thank you, Ms. Thompson.
You're past time, Mr. Bachrach, but you will get another turn.
Ms. Goodridge, go ahead, please, for five minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:43
That's your time. Thank you, Ms. Goodridge.
We'll have Ms. Shanahan for five minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:49
Thank you, Ms. Thompson and Ms. Shanahan.
Mr. Garon, you have the floor for two and a half minutes.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:52
Thank you, Dr. Poliquin and Mr. Garon.
The last round of questions will come from Mr. Bachrach for two and a half minutes, please.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:55
Ms. Thompson, that was the last question.
You won't be interrupted. Take as much time as you need to answer it.
View Sean Casey Profile
Lib. (PE)
View Sean Casey Profile
2022-06-20 17:56
Thank you, Ms. Thompson and Mr. Bachrach.
To all of our witnesses from the Public Health Agency of Canada, we appreciate your being with us. We appreciate your patience and your professionalism. I don't know that the work of the Public Health Agency of Canada has ever been more visible than in recent times. We certainly appreciate your being here with us and so patiently and professionally handling the questions that were posed to you today.
I wish you all a good evening.
Colleagues, I have a very pleasant task for you before we wrap. Today is the last meeting for our analyst Sonya Norris. Sonya will be retiring in exactly nine days.
I'll say little bit about Sonya. She earned a master's in biochemistry and spent almost a decade in clinical research. She started with the Library of Parliament 24 years ago, in 1998, and was assigned to this committee. Her first study on this committee was on natural health products. Some of the other studies she has penned include organ donation and transplantation, and assisted human reproduction.
From 2012 to 2019, she worked in the other place—on the social affairs, science and technology committee. She wrote a number of reports, including a series on pharmaceuticals, as well as healthy eating, dementia and robotics. In all, she has drafted about 26 committee reports.
I can tell you that, as the chair, I get to meet weekly with the analysts from the Library of Parliament and the clerk to plan the business of the meetings. Sonya has always been professional, pleasant and good-humoured to deal with. I'm sure that you join me in wishing her a happy and productive retirement.
Some hon. members: Hear, hear!
The Chair: To Sonya's left is Kelly Farrah. Kelly is going to be attempting to fill the large shoes left by Sonya. She certainly has the credentials, including a Master of Science in epidemiology, as well as a Master of Library and Information Science, and 15 years of experience working in the field of health technology assessment. Prior to joining the Library of Parliament, she was a pharmaceutical review manager with Canada's Drug and Health Technology Agency.
As I read it, she sounds very much like a witness as opposed to somebody who will be on our side.
She has worked with PHAC as a research analyst and with the NACI secretariat. Areas of expertise include clinical and economic evaluation of drugs, vaccines and medical devices, and methods for knowledge synthesis in the health sciences. Please join me in welcoming Kelly to our committee as the analyst.
Some hon. members: Hear, hear!
An hon. member: She only has 24 years to go.
Some hon. members: Oh, oh!
The Chair: Is it the will of the committee to adjourn the meeting?
Some hon. members: Agreed.
The Chair: We are adjourned. Thank you.
Results: 1 - 60 of 2876 | Page: 1 of 48

1
2
3
4
5
6
7
8
9
10
>
>|
Export As: XML CSV RSS

For more data options, please see Open Data